Oxidized phospholipids, linked to apolipoprotein B of oxidized LDL, are ligands for macrophage scavenger receptors

Journal of Lipid Research

Volumn 41, Issue 5, 2000, Pages 824-833

  Gillotte, Kristin L ^a   Hörkkö, Sohvi ^a   Witztum, Joseph L ^a   Steinberg, Daniel ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Oxidized LDL apolipoprotein B; Oxidized phospholipid; Scavenger receptor

Indexed keywords

APOLIPOPROTEIN B; CHOLINE; LYSINE; OXIDIZED LOW DENSITY LIPOPROTEIN; PHOSPHOLIPID; PHOSPHORUS; PROTEIN ANTIBODY; SATURATED FATTY ACID; SCAVENGER RECEPTOR;

ANIMAL CELL; ANTIGEN BINDING; ARTICLE; BINDING COMPETITION; CHEMICAL COMPOSITION; CONTROLLED STUDY; FEMALE; LIPID OXIDATION; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN LIPID INTERACTION; PROTEIN METHYLATION; RECEPTOR BINDING; STRUCTURE ACTIVITY RELATION;

ANIMALS; APOLIPOPROTEINS B; FEMALE; HUMANS; LIGANDS; LIPOPROTEINS, LDL; MACROPHAGES, PERITONEAL; MICE; OXIDATION-REDUCTION; PHOSPHOLIPIDS; PHOSPHORUS; RECEPTORS, IMMUNOLOGIC; RECEPTORS, SCAVENGER; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 0343238361     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Steinberg, D., S. Parthasarathy, T. E. Carew, J. C. Khoo, and J. L. Witztum. 1989. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N. Engl. J. Med. 320: 915-924.
2. Carew, T. E., D. C. Schwenke, and D. Steinberg. 1987. Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosis in the Watanabe heritable hyperlipidemic rabbit. Proc. Natl. Acad. Sci. USA. 84: 7725-7729.
3. Kita, T., Y. Nagano, M. Yokode, K. Ishi, N. Kume, A. Ooshima, H. Yoshida, and C. Kawai. 1987. Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholcsterolemia. Proc. Natl. Acad. Sci. USA. 84: 5928-5931.
4. Parker, R. A., T. Sabrah, M. Cap, and B. T. Gill. 1995. Relation of vascular oxidative stress, alpha-tocopherol, and hypercholesterolemia to early atherosclerosis in hamsters. Arterioscler. Thromb. Vasc. Biol. 15: 349-358.
5. Prasad, K., and J. Kalra. 1993. Oxygen free radicals and hypercholesterolemic atherosclerosis: effect of vitamin E. Am. Heart J. 125: 958-973.
6. Pratico, D., R. Tangirala, D. Rader, J. Rokach, and G. FitzGerald. 1999. Vitamin E suppresses isoprostane generation in vivo and reduces atherosclerosis in apoE-deficient mice. Nature Med. 10: 1189-1192.
7. Cyrus, T., J. L. Witztum, D. J. Rader, R. Tangirala, S. Fazio, M. F. Linton, and C. D. Funk. 1999. Disruption of the 12/15-lipoxygenase gene diminishes atherosclerosis in apoE-deficient mice. J. Clin. Invest. 103: 1487-1488.
8. Chang, M. K., C. Bergmark, A. Laurila, S. Hörkkö, K. H. Han, P. Friedman, E. Dennis, and J. L. Witztum. 1999. Monoclonal antibodies against oxidized low-density lipoprotein bind to apoptotic cells and inhibit their phagocytosis by elicited macrophages: Evidence that oxidation-specific epitopes mediate macrophage recognition. Proc. Natl. Acad. Sci. USA. 96: 6353-6358.
9. Sambrano, G., and D. Steinberg. 1995. Recognition of oxidatively damaged apoptotic cells by an oxidized LDL receptor on mouse peritoneal macrophages: role of membrane phosphatidylserine. Proc. Natl. Acad. Sci. USA. 92: 1396-1400.
10. Steinbrecher, U. P., J. L. Witztum, S. Parthasarathy, and D. Steinberg. 1987. Decrease in reactive amino groups during oxidation or endothelial cell modification of LDL. Correlation with changes in receptor-mediated catabolism. Arteriosclerosis. 7: 135-143.
11. Esterbauer, H., R. J. Schaur, and H. Zollner. 1991. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radical Biol. Med. 11: 81-128.
12. Steinbrecher, U. P. 1987. Oxidation of human low density lipoprotein results in derivatization of lysine residues of apolipoprotein B by lipid peroxide decomposition products. J. Biol. Chem. 262: 3603-3608.
13. Goldstein, J. L., Y. K. Ho, S. K. Basu, and M. S. Brown. 1979. Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc. Natl. Acad. Sci. USA. 76: 333-337.
14. Fogelman, A. M., I. Shechter, J. Seager, M. Hokom, J. S. Child, and P. A. Edwards. 1980. Malondialdehyde alteration of low density lipoproteins leads to cholesteryl ester accumulation in human monocyte-macrophages. Proc. Natl. Acad. Sci. USA 77: 2214-2218.
15. Hörkkö, S., D. Bird, E. Miller, H. Itabe, N. Leitinger, G. Subbanagounder, J. A. Berliner, P. Friedman, E. A. Dennis, L. K. Curtiss, W. Palinski, and J. L. Witztum. 1999. Monoclonal autoantibodies specific for oxidized phospholipids or oxidized phospholipid-protein adducts inhibit macrophage uptake of oxidized low-density lipoproteins. J. Clin. Invest. 103: 117-128.
16. Bird, D. A., K. L. Gillotte, S. Hörkkö, P. Friedman, E. A. Dennis, J. L. Witztum, and D. Steinberg. 1999. Receptors for oxidized low-density lipoprotein on elicited mouse peritoneal macrophages can recognize both the modified lipid moieties and the modified protein moieties: Implications with respect to macrophage recognition. Proc. Natl. Acad. Sci. USA. 96: 6347-6352.
17. Palinski, W., S. Hörkkö, E. Miller, U. P. Steinbrecher, H. C. Powell, L. K. Curtiss, and J. L. Witztum. 1996. Cloning of monoclonal autoantibodies to epitopes of oxidized lipoproteins from apo E-deficient mice. Demonstration of epitopes of oxidized LDI. in human plasma. J. Clin. Invest. 98: 800-814.
18. Havel, R. J., H. A. Eder, and J. H. Bragdon. 1955. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J. Clin. Invest. 34: 1345-1353.
19. Yagi, K. 1976. A simple fluorometric assay for lipoperoxide in blood plasma. Biochem. Med. 15: 212-216.
20. Lowry, O. H., N. J. Rosebrough, A. L. Farr, and R. J. Randall. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193: 265-275.
21. Parthasarathy, S., D. J. Printz, D. Boyd, L. Joy, and D. Steinberg. 1986. Macrophage oxidation of low density lipoprotein generates a modified form recognized by the scavenger receptor. Arteriosclerosis. 6: 505-510.
22. Bligh, E. G., and W. J. Dyer. 1959. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37: 911-917.
23. Marinetti, G. 1962. Chromatographic separation, identification, and analysis of phosphatides. J. Lipid Res. 3: 1-20.
24. Lund-Katz, S., J. A. Ibdah, J. Y. Letizia, M. T. Thomas, and M. C. Phillips. 1988. A 13C NMR characterization of lysine residues in apolipoprotein B and their role in binding to the low density lipoprotein receptor. J. Biol. Chem. 263: 13831-13838.
25. Habeeb, A. F. 1966. Determination of free amino groups in proteins by trinitrobenzenesulfonic acid. Anal. Biochem. 14: 328-336.
26. Karmen, A., M. Whyte, and D. Goodman. 1963. Fatty acid esterification and chylomicron formation during fat absorption: 1. Triglycerides and cholesterol esters. J. Lipid Res. 4: 312-321.
27. Salacinski, P. R., C. McLean, J. E. Sykes, V. V. Clement-Jones, and P. J. Lowry. 1981. Iodination of proteins, glycoproteins, and peptides using a solid-phase oxidizing agent, 1,3,4,6-tetrachloro-3a, 6a-diphenyl glycoluril (Iodogen). Anal. Biochem. 117: 136-146.
28. Hörkkö, S., E. Miller, E. Dudl, P. Reaven, L. K. Curtiss, N. J. Zvaifler, R. Terkeltaub, S. S. Pierangeli, D. W. Branch, W. Palinski, and J. L. Witztum. 1996. Antiphospholipid antibodies are directed against epitopes of oxidized phospholipids. Recognition of cardiolipin by monoclonal antibodies to epitopes of oxidized low density lipoprotein. J. Clin. Invest. 98: 815-825.
29. Fong, L. G., S. Parthasarathy, J. L. Witztum, and D. Steinberg. 1987. Nonenzymatic oxidative cleavage of peptide bonds in apoprotein B-100. J. Lipid Res. 28: 1466-1477.
30. Esterbauer, H., J. Gebicki, H. Puhl, and G. Jurgens. 1992. The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radical Biol. Med. 13: 341-390.
31. Palinski, W., S. Yla-Herttuala, M. E. Rosenfeld, S. W. Butler, S. A. Socher, S. Partbasarathy, L. K. Curtiss, and J. L. Witztum. 1990. Antisera and monoclonal antibodies specific for epitopes generated during oxidative modification of low density lipoprotein. Arteriosclerosis. 10: 325-335.
32. Esterbauer, H., G. Jurgens, O. Quehenberger, and E. Koller. 1987. Autoxidation of human low density lipoprotein: loss of polyunsaturated fatty acids and vitamin E and generation of aldehydes. J. Lipid Res. 28: 495-509.
33. Esterbauer, H., and P. Ramos. 1996. Chemistry and pathophysiology of oxidation of LDL. Rev. Physiol. Biochem. Pharmacol. 127: 31-64.
34. Ravandi, A., A. Kuksis, N. Shaikh, and G. Jackowski. 1997. Preparation of Schiff base adducts of phosphatidylcholine core aldehydes and aminophospholipids, amino acids, and myoglobin. Lipids. 32: 989-1001.
35. Kamido, H., A. Kuksis, L. Marai, and J. J. Myher. 1995. Lipid ester-bound aldehydes among copper-catalyzed peroxidation products of human plasma. J Lipid Res. 36: 1876-1886.
36. Karakatsani, A., T. Liapikos, A. Troganis, and D. Tsoukatos. 1998. Involvement of phospholipids in apolipoprotein B modification during low density lipoprotein oxidation. Lipids. 33: 1159-1162.
37. Tertov, V. V., V. V. Kaplun, S. N. Dvoryantsev, and A. N. Orekhov. 1995. Apolipoprotein B-bound lipids as a marker for evaluation of low density lipoprotein oxidation in vivo. Biochem. Biophys. Res. Commun. 214: 608-613.
38. Terpstra, V., D. Bird, and D. Steinberg, 1998. Evidence that the lipid moiety of oxidized low density lipoprotein plays a role in its interaction with macrophage receptors. Proc. Natl. Sci. USA. 95: 1806-1811.
39. Itabe, H., E. Takeshima, H, Iwasaki, J. Kimura, Y. Yoshida, T. Imanaka, and T. Takano. 1994. A monoclonal antibody against oxidized lipoprotein recognizes foam cells in atherosclerotic lesions. Complex formation of oxidized phosphatidylcholines and polypeptides. J. Biol. Chem. 269: 15274-15279.
40. Boullier, A., K. L. Gillotte, S. Hörkkö, P. Friedman, E. A. Dennis, J. L. Witztum, D. Steinberg, and O. Quehenberger. 2000. The binding of oxidized LDL to mouse CD36 is mediated in part by oxidized phospholipids that are associated with both the lipid and protein moieties of the lipoprotein. J. Biol. Chem. (In press).